Search filters

Schneider Group acquires Nova Traffic

The internationally oriented Schneider Group, a Invision portfolio company and one of Switzerland's leading freight forwarding companies, has acquired the globally active forwarding agent Nova Traffic with locations in Kloten and...

FoRx Therapeutics AG raises EUR 10M Seed-Financing round

FoRx Therapeutics AG, a Basel-based biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress (DRS) pathways activated in cancer, completes a EUR 10M seed-financing round led by M...

RLF sells its subsidiary to Sonnet BioTherapeutics Holdings, Inc

RELIEF THERAPEUTICS Holding SA (SIX:RLF; "Relief Holding") announces today the closing of the binding Share Exchange Agreement for the acquisition by Sonnet BioTherapeutics, Inc. ("Sonnet"), now a subsidiary of Sonnet...

Dubai's DP World and Swissterminal enter strategic partnership

DP World and Swissterminal, the leading container terminal operator in Switzerland, have entered a strategic partnership. DP World will take a stake of 44% in Swissterminal Holding AG with the Mayer family, the business' founder,...

AFINUM acquires majority stake in Swiss Interconnect Group

AFINUM Achte Beteiligungsgesellschaft mbH & Co. KG has acquired a majority stake in the Swiss Interconnect Group with headquarters in the canton of Valais, Switzerland. The Swiss Interconnect Group is a leading provider of high...

Numab and Sunshine Guojian form partnership

3SBio Inc.’s subsidiary Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (“Sunshine Guojian”) and Numab have formed a partnership focusing on the development and commercialization of a portfolio of novel multi-specific...

ARTIDIS announces CHF 8.8M seed financing round

ARTIDIS AG ("ARTIDIS"), a privately held healthtech company, announced the successful closure of a CHF 8.8M seed financing in two rounds, securing early clinical validation and the next development phase towards market entry in...

Kuros Biosciences AG completes rights offering and share placement

Kuros Biosciences (SIX: KURN) completes a rights offering and share placement in which a total of 6,405,022 new registered shares of Kuros sourced from the ordinary and authorized share capital with a nominal value of CHF 1.00...

ImmunOs Therapeutics AG raises CHF 15M in Series A Financing

ImmunOs Therapeutics AG, a Swiss biotechnology company and leading developer of a next generation innate immunity focused immunotherapy platform for cancer, announced today the closing of a Series A financing of CHF 15 million....

Public Offer of BFW Holding AG for BFW Liegenschaften AG

On November 29, 2019 BFW Holding AG published a friendly public offer for the SIX listed A shares of BFW Liegenschaften AG (going private). VISCHER (partners Felix W. Egli and Adrian Dörig as well as associates Sebastian Flückiger...

You are currently offline. Some pages or content may fail to load.